These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis. Sperry BW, Ibrahim A, Negishi K, Negishi T, Patel P, Popović ZB, Culver D, Brunken R, Marwick TH, Tamarappoo B. Am J Cardiol; 2017 May 15; 119(10):1663-1669. PubMed ID: 28343598 [Abstract] [Full Text] [Related]
23. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J. J Nucl Med; 2003 Jul 15; 44(7):1030-6. PubMed ID: 12843216 [Abstract] [Full Text] [Related]
26. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET. Yamamoto A, Nagao M, Watanabe E, Imamura Y, Suzuki A, Fukushima K, Ando K, Nakao R, Sakai A, Momose M, Sakai S, Hagiwara N. J Nucl Cardiol; 2021 Jun 15; 28(3):919-929. PubMed ID: 33728571 [Abstract] [Full Text] [Related]
28. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, Narasimhan C. Int J Cardiol; 2017 Feb 01; 228():717-722. PubMed ID: 27886616 [Abstract] [Full Text] [Related]
38. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, Agrawal M, Madan R, Taqueti VR, Steigner M, Skali H, Kwong RY, Stewart GC, Dorbala S, Di Carli MF, Blankstein R. Circ Cardiovasc Imaging; 2018 Jan 01; 11(1):e007030. PubMed ID: 29335272 [Abstract] [Full Text] [Related]
39. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. J Nucl Med; 2004 Dec 01; 45(12):1989-98. PubMed ID: 15585472 [Abstract] [Full Text] [Related]
40. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB. Eur J Nucl Med Mol Imaging; 2016 Feb 01; 43(2):259-269. PubMed ID: 26359191 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]